The Lipid Energy Model: Cholesterol on Low-Carb Diets
Introduction
One of the most striking findings in people following low-carbohydrate or ketogenic diets is the dramatic change in blood cholesterol levels. While many see improvements—lower triglycerides and higher HDL cholesterol—some experience a sharp rise in LDL cholesterol that confuses both patients and clinicians.
To explain this phenomenon, researchers have proposed the Lipid Energy Model (LEM). First described by engineer and citizen scientist Dave Feldman and collaborators, the model suggests that rising LDL cholesterol in lean, insulin-sensitive individuals may not reflect disease, but rather an adaptation in energy transport.
As low-carb nutrition becomes more widespread, understanding the Lipid Energy Model is essential for interpreting lab results, assessing cardiovascular risk, and guiding appropriate monitoring strategies.
🎧 Listen to the Episode: The Lipid Energy Model Explained
High LDL but perfect metabolic health? You might be a Lean Mass Hyper-Responder. In this episode, we explore the Lipid Energy Model and what it means for your heart health.
▶️ Click play below to listen and discover how to bring clarity—and context—to your lab results.
What Is the Lipid Energy Model?
The Lipid Energy Model (LEM) is a framework that explains why some individuals—particularly those who are lean, insulin-sensitive, and physically active—develop significant increases in LDL cholesterol when adopting a low-carbohydrate or ketogenic diet.
According to the model, these lipid changes are not random. Instead, they reflect a shift in how the body packages, transports, and delivers energy under conditions of carbohydrate restriction.
In a typical mixed diet, glucose provides much of the body’s fuel. But when carbohydrates are limited, the body relies more heavily on fatty acids and ketones for energy. To support this, the liver releases more triglyceride-rich lipoproteins (VLDL particles), which transport fat to tissues. As these VLDL particles deliver triglycerides, they remodel into LDL particles—raising circulating LDL levels.
In this way, the Lipid Energy Model views elevated LDL in low-carb individuals as a byproduct of enhanced fat transport, not necessarily as a marker of pathology.
Figure 1. The Lipid Energy Model. (A) In the context of carbohydrate restriction, (1) glycogen depletion and (2) changes in circulating hormones stimulate hormone-sensitive lipase (HSL)-mediated secretion of non-esterified fatty acids (NEFA) by adipocytes to fuel oxidative tissues. (3) The liver captures circulating NEFAs and repackages them into triglycerides (TG), (4) secreted aboard VLDL. (5) Increased lipoprotein-lipase (LPL)-mediated VLDL turnover generates increased LDL-C and HDL-C. (Further details can be found in the main text.) The role of chylomicrons in the post-prandial state is presented later in the text. (B) The magnitude of carbohydrate restriction, adiposity, and energy expenditure each contribute, as independent variables, to the degree of LPL-mediated VLDL turnover and, thereby, to the magnitude of change of the triad components.
How the Model Works
The Lipid Energy Model (LEM) centers on the idea that during carbohydrate restriction, the body adapts by shifting to fat as its primary energy source. This adaptation changes how lipoproteins behave in circulation:
Increased VLDL Secretion
The liver packages triglycerides into very low-density lipoproteins (VLDL).
These particles deliver fat-based energy to muscles and other tissues.
Triglyceride Delivery and Remodeling
As VLDL unloads triglycerides, it becomes progressively smaller and denser.
This remodeling produces LDL particles, which remain in circulation.
Rise in LDL Cholesterol
With higher fat flux in lean, active individuals, more VLDL is secreted.
This leads to a higher turnover into LDL particles, explaining why LDL cholesterol can rise significantly in some people.
Characteristic Lipid Profile
High LDL-C (often >200 mg/dL).
High HDL-C (protective marker).
Low triglycerides (reflecting efficient fat utilization).
This triad—seen especially in Lean Mass Hyper-Responders—is consistent with the predictions of the Lipid Energy Model.
Key Predictions of the Model
The Lipid Energy Model (LEM) makes several testable predictions about how cholesterol and lipoproteins behave under carbohydrate restriction, particularly in lean, insulin-sensitive individuals:
1. LDL Cholesterol Rises with Fat Flux
Individuals with low body fat and high energy demands may see marked increases in LDL-C when carbohydrate intake is very low, because their bodies depend heavily on fat transport through lipoproteins.
2. HDL Cholesterol Increases, Triglycerides Decrease
The model predicts a lipid profile characterized by high HDL-C and low triglycerides, reflecting efficient fat metabolism and favorable insulin sensitivity.
3. Diet Composition Matters
The degree of carbohydrate restriction, total caloric intake, and fat type (saturated vs unsaturated) influence how strongly LDL rises. Reintroducing moderate carbohydrates can lower LDL-C in some cases, consistent with the model.
4. Not Everyone Responds the Same
The LEM explains why some individuals—especially Lean Mass Hyper-Responders—see dramatic LDL changes, while others experience only modest shifts. Genetic and metabolic differences play a role in determining the response.
These predictions highlight that elevated LDL-C in the context of a ketogenic diet may not always signify the same risk as in populations with insulin resistance or high triglycerides, but the long-term consequences remain uncertain.
Controversies and Evidence
The Lipid Energy Model (LEM) offers a compelling explanation for why LDL cholesterol can rise dramatically on low-carbohydrate diets, but it remains controversial in the medical community.
Traditional View:
LDL cholesterol and ApoB-containing lipoproteins are causally linked to atherosclerosis.
From this perspective, any rise in LDL—regardless of diet or metabolic health—should be considered a significant cardiovascular risk.
Decades of randomized controlled trials and genetic studies support lowering LDL as a way to reduce heart disease events.
LEM Perspective:
In lean, insulin-sensitive individuals, rising LDL may reflect increased energy trafficking, not necessarily a pathological state.
Supporters argue that context matters: low triglycerides, high HDL, and low inflammation may alter the risk associated with high LDL.
Ongoing citizen science projects and pilot studies are testing whether LMHRs (Lean Mass Hyper-Responders) actually experience higher rates of plaque buildup.
Current Evidence:
Case reports and small trials show consistent patterns of lipid changes in LMHRs, but no long-term outcome data exist.
Imaging studies such as coronary artery calcium (CAC) scoring and CT angiography are being used to track whether high LDL in this context leads to accelerated atherosclerosis. Results remain inconclusive.
In short, the LEM challenges conventional wisdom, but until larger clinical studies are completed, most experts recommend cautious monitoring of individuals with markedly elevated LDL on ketogenic diets.
How Lab Testing Helps
For individuals following low-carbohydrate or ketogenic diets, and especially those who fit the Lean Mass Hyper-Responder profile, laboratory testing is essential for understanding how lipid changes fit into their overall health. The Lipid Energy Model (LEM) highlights that standard cholesterol numbers may not tell the full story—making advanced testing and longitudinal monitoring crucial.
Key tests include:
Standard Lipid Panel: Tracks total cholesterol, LDL-C, HDL-C, and triglycerides to establish the baseline LEM pattern.
Apolipoprotein B (ApoB): A direct measure particle number; considered a more accurate risk marker than LDL-C.
LDL Particle Number (LDL-P) and Size: Advanced lipid testing (e.g., Cardio IQ) distinguishes between large buoyant LDL and small dense LDL, both relevant to cardiovascular risk.
Inflammatory Markers: High-sensitivity C-reactive protein (hs-CRP) and homocysteine provide insight into whether lipid elevations are accompanied by vascular inflammation.
Glucose and Insulin Testing: Since insulin sensitivity strongly influences lipid metabolism, markers like fasting glucose, HbA1c, and fasting insulin are critical for context.
At QuickLab Mobile, patients in Miami can access these tests through at-home blood collection, making it easier to track trends over time without repeated clinic visits. This convenience allows individuals experimenting with low-carb diets to monitor both the benefits and potential risks of their metabolic adaptations.
Conclusion
The Lipid Energy Model (LEM) offers a new perspective on why LDL cholesterol can rise in individuals following low-carbohydrate diets. Rather than being purely pathological, these changes may reflect a shift in energy transport—particularly in lean, insulin-sensitive people. Still, the model challenges long-standing medical views, and the long-term cardiovascular risks remain uncertain.
What is clear is the importance of ongoing monitoring. Advanced lipid testing, ApoB, inflammatory markers, and glucose-insulin assessments provide the context needed to interpret lab results and guide personalized nutrition strategies.
At QuickLab Mobile, we simplify this process by offering at-home lab testing, giving patients and practitioners the data they need without the hassle of repeated clinic visits.
👉 Take control of your health today. Book Your At-Home Test with QuickLab Mobile.
Resources
Disclaimer:
The information provided in this blog, podcast, and associated content is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. The content shared is based on reputable sources, medical literature, and expert insights, but it should not be used as a replacement for direct consultation with a licensed healthcare provider.
No Doctor-Patient Relationship: Engaging with this content does not create a doctor-patient relationship between you and QuickLabMobile or any contributors. Always consult with a qualified physician, specialist, or healthcare professional before making any medical decisions, changing your treatment plan, or starting/stopping any medications.
Not a Substitute for Medical Advice: While we strive to provide accurate and up-to-date information, medicine is constantly evolving. New research, treatments, and medical recommendations may emerge, and individual health conditions can vary. Do not rely solely on this content for health decisions. If you are experiencing symptoms, have concerns about your health, or require medical assistance, seek immediate care from a licensed medical professional.
Emergency Situations: If you are experiencing a medical emergency, such as difficulty breathing, chest pain, signs of a stroke, or any other life-threatening condition, call 911 (or your local emergency services) immediately. Do not delay seeking emergency care based on information provided here.
Liability Disclaimer: QuickLabMobile, its contributors, and any associated entities do not assume liability for any damages, harm, or adverse outcomes resulting from the use, interpretation, or misuse of the information provided in this content. You are responsible for your own healthcare decisions and should always verify information with a trusted medical professional.
External Links & References: This content may include links to external sources, medical studies, or third-party websites for further reading. These links are provided for convenience and informational purposes only. QuickLabMobile does not endorse, control, or take responsibility for the accuracy of external content. Always verify information with authoritative sources such as the CDC, NIH, WHO, or Mayo Clinic.
Final Note: Your health is unique, and what works for one person may not be suitable for another. Stay informed, ask questions, and always prioritize professional medical guidance.
